Prospective, Randomized Study of 2 Different Wound Dressings
- Conditions
- Hip-surgeryKnee-surgerySpinal-surgery
- Interventions
- Device: Mepilex® Border Post-OpDevice: standard wound dressing
- Registration Number
- NCT01988818
- Lead Sponsor
- University of Cologne
- Brief Summary
The primary objective of this investigation is to evaluate the performance of a self-adhesive absorbent post-operative dressing coated with a soft silicone layer in minimize the risk of the development of blistering in subjects after hip or knee arthroplasty or spinal surgery in comparison to a standard wound dressing The secondary objectives are to evaluate:
* the performance of the dressing
* the comfort, conformability and the acceptability of the dressing
* pain before, during and after dressing removal
* the overall cost regarding dressing wear time, time to do dressing change and personal resources needed
- Detailed Description
A monocentre, post CE-mark, randomized clinical trial will be conducted at the University of Cologne, Department of Orthopedics and Trauma Surgery.
Male or female subjects, 18 years and above, undergoing hip, knee or spinal surgery with an expected hospital stay for 4 days or more will be included in the trial. Individual trial duration will be for 7 days (follow-up).
Two hundred subjects will be included in the trial, i.e. 100 subjects per arm. The treatment arm (either new or standard wound dressing) will be assigned by randomization stratified by type of surgery (i.e. hip, knee or spine).
AEs/ADEs/unexpected events with the device may be documented by relevant photos at time. All photos shall include a sticker marked with subject code, visit number/date and time.
Outcome Measures
Primary variable:
• Development of blistering from day 0 to day 6 post surgery Photo documentation will be evaluated in a blinded manner by the Clinical Evaluation Committee (CEC).
Secondary variables:
* Other wound complications (i.e. leakage, inflammation, infection)
* Number of dressing changes
* Pain before, during and after dressing removal (VA scale)
* Performance and acceptability of the dressing (4 point rating scale)
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 200
- Age ≥18years
- Have an expected total length of stay of 4 or more days
- Undergoing elective primary arthroplasty of the hip or knee or spinal surgery
- Undergoing hip surgery with a standard access
- Give their written informed consent to participate
- Dressing size does not fit the incision area
- Known allergy/hypersensitivity to any of the components of the dressing
- Multi-trauma
- Undergoing arthroplasty or spine surgery due to tumour or infection?
- Fractures
- Wound at the surgical site prior to surgery
- Neurological deficit of operated side (hemiplegia, etc.)
- Subject has documented skin disease at time of enrolment, as judged by the investigator
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Mepilex® Border Post-Op Mepilex® Border Post-Op wound dressing with Mepilex® Border Post-Op with Safetac®Technology, self-adherent soft silicone surgical dressing Standard wound dressing standard wound dressing As comparator will be used a standard Cosmopor E®adhesive, island wound dressing (Paul Hartmann LTD)after hip or knee arthroplasty or spinal surgery
- Primary Outcome Measures
Name Time Method Blistering 0-6 days Development of blistering from day 0 to day 6 post surgery Photo documentation will be evaluated in a blinded manner by the Clinical Evaluation Committee (CEC).
- Secondary Outcome Measures
Name Time Method wound complications 0-6 days Other wound complications (i.e. leakage, inflammation, infection)
dressing changes 0-6 days Number of dressing changes
pain 0-6 days Pain before, during and after dressing removal (VA scale)
performance and acceptability 0-6 days Performance and acceptability of the dressing (4 point rating scale)
Trial Locations
- Locations (1)
University Hospital Cologne
🇩🇪Cologne, Germany